Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
Purvalanol A
CDK1
CDK
7475.067
uM
inf
inf
1.0500 1.0500 0.0000 -0.0408
-9.2547
2.4078
Hs 578T
TNBC
Basal B
Purvalanol A
CDK1
CDK
7473.067
uM
inf
inf
0.9516 0.9516 0.0000 -0.0284
-0.2407
2.6736
Hs 578T
TNBC
Basal B
Purvalanol A
CDK1
CDK
7474.067
uM
inf
inf
0.7787 0.7787 0.0000 -0.0154
0.1964
2.7442
Hs 578T
TNBC
Basal B
Ribavirin
15352.211
uM
inf
inf
0.9699 0.9699 0.0000 -0.0304
-0.7752
2.5357
Hs 578T
TNBC
Basal B
SB-3CT
MMP2/9
MMP
10694.144
uM
30.17320
28.2630
0.1399 0.1382 4.9470 0.0296
0.9760
2.1636
Hs 578T
TNBC
Basal B
Selumetinib
MEK
MAPK
10694.146
uM
40.77980
30.94250
0.4689 0.0654 0.5078 0.1117
0.9790
2.2821
Hs 578T
TNBC
Basal B
Sigma A6730
AKT
AKT
10694.153
uM
14.9020
25.71640
-0.7493 -1.0000 2.0135 0.1776
0.9967
2.2940
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7474.069
uM
inf
inf
1.0500 1.0500 0.0000 -0.0115
-0.0565
2.5606
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7473.069
uM
inf
inf
0.9657 0.9657 0.0000 0.0026
0.0000
3.2103
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7475.069
uM
inf
inf
0.9609 0.9609 0.0000 0.0540
0.2883
2.7183
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7861.068
uM
inf
0.01657
0.6677 0.7424 5.0000 0.1662
0.8378
1.5554
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7475.084
uM
inf
228.94580
0.7420 0.7418 4.9998 -0.0088
0.8449
2.7804
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7473.084
uM
1210.01560
999.18010
0.6509 0.3033 4.8722 -0.0111
0.8989
2.0337
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7474.084
uM
474.21380
590.74280
-0.8699 -1.0000 5.0000 0.1198
0.9846
2.6631
Hs 578T
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7473.067
uM
7.10170
8.68080
-0.8838 -0.8632 4.9954 0.4373
0.9845
2.6736
Hs 578T
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7474.067
uM
5.45640
8.59690
-0.8618 -0.9023 2.2684 0.4409
0.9946
2.7442
Hs 578T
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7475.067
uM
5.38430
7.34630
-0.8808 -0.8873 3.2844 0.4639
0.9981
2.4078
Hs 578T
TNBC
Basal B
Taxol
TUBB
TUBB
7864.002
uM
0.00409
0.00803
-0.5125 -0.4792 0.9967 0.9577
0.9913
1.5910
Hs 578T
TNBC
Basal B
Taxol
TUBB
TUBB
9511.002
uM
0.00407
0.00628
-0.6889 -0.5691 1.7559 1.0292
0.9934
1.1960
Hs 578T
TNBC
Basal B
TCS 2312
CHK1
CHK
10694.152
uM
0.92247
1.72570
-0.4983 -0.5189 1.1366 0.3570
0.9949
2.4238
Hs 578T
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
10694.148
uM
inf
inf
0.7268 0.7268 0.0000 0.0766
0.5658
2.4626
Hs 578T
TNBC
Basal B
Temsirolimus
MTOR
MTOR
10694.144
uM
32.21280
53.07380
-0.7824 -1.0000 2.2002 0.2318
0.9539
2.1636
Hs 578T
TNBC
Basal B
Topotecan
TOP1
TOP
7863.007
uM
19.50830
171.5730
0.0548 -1.0000 0.5053 0.1773
0.9480
1.4578
Hs 578T
TNBC
Basal B
Torkinib
15352.211
uM
0.09021
0.26878
-0.3566 -0.4047 0.5431 0.5802
0.9760
2.5357
Hs 578T
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10694.15
uM
0.52547
1.86090
-0.3324 -0.5170 0.5615 0.3657
0.9595
2.2191